MECHANISMS OF RESISTANCE TO THE 4-QUINOLONE ANTIBACTERIAL AGENTS

被引:15
作者
CRUMPLIN, GC
机构
[1] Biology Department, University of York, YO15D, York
关键词
D O I
10.1093/jac/26.suppl_F.131
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Because of the close structural relationship of the fluorinated 4-quinolones to the parent compound nalidixic acid the mechanism of resistance is often perceived to be the same. However, it is clear that whilst the mechanism of resistance to fluorinated 4-quinolones is essentially the same, strains that are selected as resistant to nalidixic acid generally retain sensitivity to the newer agents. A number of mutations in the chromosome of Escherichia coli have been identified and these are described. These mutations affect the interaction of quinolones with their presumed targets (DNA gyrases) and the transport of quinolones through the cell membrane. A small number of other mutations giving rise to low-level resistance to nalidixic acid, which affect neither gyrase nor membrane function, are also recognized. Despite the recognition of these mutations, the practical application of this information is hampered by lack of knowledge of the normal uptake mechanisms, the processes involved in selection and maintenance of resistance, the relationship of resistance to pathogenicity and the frequency of occurrence of these mutations. © 1990 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:131 / 144
页数:14
相关论文
共 61 条
  • [1] CLINICAL ISOLATE OF CITROBACTER-FREUNDII HIGHLY RESISTANT TO NEW QUINOLONES
    AOYAMA, H
    FUJIMAKI, K
    SATO, K
    FUJII, T
    INOUE, M
    HIRAI, K
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) : 922 - 924
  • [2] NORFLOXACIN RESISTANCE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI
    AOYAMA, H
    SATO, K
    KATO, T
    HIRAI, K
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) : 1640 - 1641
  • [3] STUDIES ON MECHANISM OF ACTION OF NALIDIXIC-ACID
    BOURGUIG.GJ
    LEVITT, M
    STERNGLA.R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 4 (04) : 479 - 486
  • [4] CHARACTERIZATION OF MECHANISMS OF QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA STRAINS ISOLATED INVITRO AND INVIVO DURING EXPERIMENTAL ENDOCARDITIS
    CHAMBERLAND, S
    BAYER, AS
    SCHOLLAARDT, T
    WONG, SA
    BRYAN, LE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) : 624 - 634
  • [5] Crumplin G. C., 1990, Reviews in Medical Microbiology, V1, P67
  • [6] DEVELOPMENT OF RESISTANCE TO OFLOXACIN
    CRUMPLIN, GC
    ODELL, M
    [J]. DRUGS, 1987, 34 : 1 - 8
  • [7] CRUMPLIN GC, 1990, 4 QUINOLONES ANTIBAC, P257
  • [8] CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES
    CULLEN, ME
    WYKE, AW
    KURODA, R
    FISHER, LM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 886 - 894
  • [9] ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF PSEUDOMONAS-AERUGINOSA ASSOCIATED WITH SELECTIVE RESISTANCE TO QUINOLONES
    DAIKOS, GL
    LOLANS, VT
    JACKSON, GG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) : 785 - 787
  • [10] DANG P, 1988, REV INFECT DIS, V10, P899